Prairie Voles as a Model to Screen Medications for the Treatment of Alcoholism and Addictions

Int Rev Neurobiol. 2016:126:403-21. doi: 10.1016/bs.irn.2016.02.019. Epub 2016 Mar 21.

Abstract

Most preclinical studies of medications to treat addictions are performed in mice and rats. These two rodent species belong to one phylogenetic subfamily, which narrows the likelihood of identifying potential mechanisms regulating addictions in other species, ie, humans. Expanding the genetic diversity of organisms modeling alcohol and drug abuse enhances our ability to screen for medications to treat addiction. Recently, research laboratories adapted the prairie vole model to study mechanisms of alcohol and drugs of abuse. This development not only expanded the diversity of genotypes used to screen medications, but also enhanced capabilities of such screens. Prairie voles belong to 3-5% of mammalian species exhibiting social monogamy. This unusual trait is reflected in their ability to form lasting long-term affiliations between adult individuals. The prairie vole animal model has high predictive validity for mechanisms regulating human social behaviors. In addition, these animals exhibit high alcohol intake and preference. In laboratory settings, prairie voles are used to model social influences on drug reward and alcohol consumption as well as effects of addictive substances on social bonding. As a result, this species can be adapted to screen medications whose effectiveness could be (a) resistant to social influences promoting excessive drug taking, (b) dependent on the presence of social support, and (c) medications affecting harmful social consequences of alcohol and drug abuse. This report reviews the literature on studies of alcohol and psychostimulants in prairie voles and discusses capabilities of this animal model as a screen for novel medications to treat alcoholism and addictions.

Keywords: Alcoholism; Animal model; Drug abuse; Pair bonding; Prairie vole.

Publication types

  • Review

MeSH terms

  • Alcoholism / drug therapy*
  • Animals
  • Arvicolinae
  • Central Nervous System Stimulants / therapeutic use*
  • Disease Models, Animal*
  • Drug Evaluation, Preclinical / methods*
  • Ethanol / therapeutic use*
  • Humans
  • Substance-Related Disorders / drug therapy*

Substances

  • Central Nervous System Stimulants
  • Ethanol